ELAN Corporation has received the approval of the US Food and Drugs Administration to market Zanaflex, a new oral treatment for muscular spasticity. Zanaflex is the first of six neurological products in Elan's research and development pipeline to reach the market place and will be the first product to be marketed since Elan's £406 million takeover of Athena Neuro-sciences.
US approves Elan drug
ELAN Corporation has received the approval of the US Food and Drugs Administration to market Zanaflex, a new oral treatment for…
IN THIS SECTION
Erin King named World Rugby’s Breakthrough Player of the Year
TV View: Rúben Amorim, Sam Prendergast and the dawn of new messiahs
The Irish Times view on Cop29: multilateral approach on climate just about hangs on
Na Fianna ride out the storm to reach a second Leinster final
Up to 2ft of water in streets of Killybegs as calls are made to reopen emergency flooding scheme
Business Today
Get the latest business news and commentary from our expert business team in your inbox every weekday morning